San Diego’s Pfenex Inc. (JOBS), a Dow Spinout, Signs Merck & Co., Inc. (JOBS) to $52M Licensing Deal

Bookmark and Share

Xconomy.com -- Pfenex, which just announced its presence in San Diego last week, today says it has granted Merck an exclusive worldwide license to use its technology to produce specific proteins for use in developing an undisclosed vaccine.

Back to news